India  

Single jab of Pfizer, AstraZeneca offers 60 per cent protection: Lancet study

Zee News Thursday, 24 June 2021
The Lancet study said, "Single-dose vaccination with either the AstraZeneca or the Pfizer COVID-19 vaccine reduces the risk of SARS-CoV-2 in older residents in long-term care facilities." 
0
shares
ShareTweetSavePostSend
 

You Might Like


Related videos from verified sources

Deadly Delta Variant Taking Over the World [Video]

Deadly Delta Variant Taking Over the World

LONDON — The delta variant is becoming the dominant strain of coronavirus worldwide, according to the WHO, and its combination of high transmissibility, high severity, and escape from vaccines makes..

Credit: TomoNews US     Duration: 02:34Published
Johnson & Johnson's Janssen COVID-19 Vaccine Approved In UK [Video]

Johnson & Johnson's Janssen COVID-19 Vaccine Approved In UK

Johnson & Johnson's Janssen COVID-19 Vaccine , Approved In UK. Janssen's single-dose coronavirus vaccine has been approved for use in the U.K. . BBC News reports vaccine trials showed it to be 85%..

Credit: Wibbitz Top Stories     Duration: 00:57Published